Scolaris Content Display Scolaris Content Display

Comparison 1 Single versus combination, symptomatic regimen, Outcome 1 Mean FEV1 at end of course (% pred).
Figuras y tablas -
Analysis 1.1

Comparison 1 Single versus combination, symptomatic regimen, Outcome 1 Mean FEV1 at end of course (% pred).

Comparison 1 Single versus combination, symptomatic regimen, Outcome 2 Mean FVC at end of course (% pred).
Figuras y tablas -
Analysis 1.2

Comparison 1 Single versus combination, symptomatic regimen, Outcome 2 Mean FVC at end of course (% pred).

Comparison 1 Single versus combination, symptomatic regimen, Outcome 3 Mean RV at end of course (% pred).
Figuras y tablas -
Analysis 1.3

Comparison 1 Single versus combination, symptomatic regimen, Outcome 3 Mean RV at end of course (% pred).

Comparison 1 Single versus combination, symptomatic regimen, Outcome 4 Mean TLC at end of course (% pred).
Figuras y tablas -
Analysis 1.4

Comparison 1 Single versus combination, symptomatic regimen, Outcome 4 Mean TLC at end of course (% pred).

Comparison 1 Single versus combination, symptomatic regimen, Outcome 5 Mean RV/TLC at end of course (% pred).
Figuras y tablas -
Analysis 1.5

Comparison 1 Single versus combination, symptomatic regimen, Outcome 5 Mean RV/TLC at end of course (% pred).

Comparison 1 Single versus combination, symptomatic regimen, Outcome 6 Mean PFR at end of course (% pred).
Figuras y tablas -
Analysis 1.6

Comparison 1 Single versus combination, symptomatic regimen, Outcome 6 Mean PFR at end of course (% pred).

Comparison 1 Single versus combination, symptomatic regimen, Outcome 7 Mean MMEF at end of course (% pred).
Figuras y tablas -
Analysis 1.7

Comparison 1 Single versus combination, symptomatic regimen, Outcome 7 Mean MMEF at end of course (% pred).

Comparison 1 Single versus combination, symptomatic regimen, Outcome 8 Mean Schwachman score at end of course.
Figuras y tablas -
Analysis 1.8

Comparison 1 Single versus combination, symptomatic regimen, Outcome 8 Mean Schwachman score at end of course.

Comparison 1 Single versus combination, symptomatic regimen, Outcome 9 Number of Pseudomonas isolates eradicated at end of course.
Figuras y tablas -
Analysis 1.9

Comparison 1 Single versus combination, symptomatic regimen, Outcome 9 Number of Pseudomonas isolates eradicated at end of course.

Comparison 1 Single versus combination, symptomatic regimen, Outcome 10 Mean change Pseudomonas density in cfu/g at end of course.
Figuras y tablas -
Analysis 1.10

Comparison 1 Single versus combination, symptomatic regimen, Outcome 10 Mean change Pseudomonas density in cfu/g at end of course.

Comparison 1 Single versus combination, symptomatic regimen, Outcome 11 Number adverse events.
Figuras y tablas -
Analysis 1.11

Comparison 1 Single versus combination, symptomatic regimen, Outcome 11 Number adverse events.

Comparison 1 Single versus combination, symptomatic regimen, Outcome 12 Number readmitted.
Figuras y tablas -
Analysis 1.12

Comparison 1 Single versus combination, symptomatic regimen, Outcome 12 Number readmitted.

Comparison 1 Single versus combination, symptomatic regimen, Outcome 13 Mean time to next course of antibiotics (weeks).
Figuras y tablas -
Analysis 1.13

Comparison 1 Single versus combination, symptomatic regimen, Outcome 13 Mean time to next course of antibiotics (weeks).

Comparison 1 Single versus combination, symptomatic regimen, Outcome 14 Mean WBC count at end of course.
Figuras y tablas -
Analysis 1.14

Comparison 1 Single versus combination, symptomatic regimen, Outcome 14 Mean WBC count at end of course.

Comparison 1 Single versus combination, symptomatic regimen, Outcome 15 Number resistant strains.
Figuras y tablas -
Analysis 1.15

Comparison 1 Single versus combination, symptomatic regimen, Outcome 15 Number resistant strains.

Comparison 1. Single versus combination, symptomatic regimen

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Mean FEV1 at end of course (% pred) Show forest plot

2

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

1.1 at 10 to 14 days

2

93

Mean Difference (IV, Fixed, 95% CI)

5.25 [‐9.14, 19.64]

1.2 at 2 to 8 weeks

1

41

Mean Difference (IV, Fixed, 95% CI)

0.5 [‐57.36, 58.36]

2 Mean FVC at end of course (% pred) Show forest plot

2

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

2.1 at 10 to 14 days

2

93

Mean Difference (IV, Fixed, 95% CI)

1.84 [‐11.44, 15.12]

2.2 at 2 to 8 weeks

1

41

Mean Difference (IV, Fixed, 95% CI)

6.90 [‐50.50, 64.30]

3 Mean RV at end of course (% pred) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

4 Mean TLC at end of course (% pred) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

5 Mean RV/TLC at end of course (% pred) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

5.1 at 2 weeks

1

64

Mean Difference (IV, Fixed, 95% CI)

‐1.40 [‐40.68, 37.88]

5.2 At 2 to 8 weeks

1

40

Mean Difference (IV, Fixed, 95% CI)

‐5.20 [‐54.27, 43.87]

6 Mean PFR at end of course (% pred) Show forest plot

2

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

6.1 at 10 to 14 days

2

91

Mean Difference (IV, Fixed, 95% CI)

3.21 [‐11.49, 17.91]

6.2 At 2 to 8 weeks

1

40

Mean Difference (IV, Fixed, 95% CI)

2.30 [‐60.90, 65.50]

7 Mean MMEF at end of course (% pred) Show forest plot

2

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

7.1 at 10 to 14 days

2

91

Mean Difference (IV, Fixed, 95% CI)

7.17 [‐8.22, 22.55]

7.2 At 2 to 8 weeks

1

40

Mean Difference (IV, Fixed, 95% CI)

‐1.90 [‐73.27, 69.47]

8 Mean Schwachman score at end of course Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

9 Number of Pseudomonas isolates eradicated at end of course Show forest plot

3

72

Peto Odds Ratio (Peto, Fixed, 95% CI)

5.63 [2.12, 14.94]

10 Mean change Pseudomonas density in cfu/g at end of course Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

11 Number adverse events Show forest plot

2

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

11.1 local erythema / irritation

2

131

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.46 [0.09, 2.36]

11.2 generalised rash

1

20

Peto Odds Ratio (Peto, Fixed, 95% CI)

6.16 [0.12, 316.67]

11.3 fever

1

20

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.81 [0.05, 14.14]

11.4 renal impairment (increased creatinine by 50%)

1

80

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.54 [0.15, 15.56]

11.5 auditory impairment

1

76

Peto Odds Ratio (Peto, Fixed, 95% CI)

5.86 [0.11, 305.44]

11.6 proteinuria

1

63

Peto Odds Ratio (Peto, Fixed, 95% CI)

3.62 [0.68, 19.30]

12 Number readmitted Show forest plot

2

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

12.1 in 1 month

1

16

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.14 [0.01, 1.30]

12.2 in 80 days

1

76

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.30 [0.12, 0.73]

13 Mean time to next course of antibiotics (weeks) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

14 Mean WBC count at end of course Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

15 Number resistant strains Show forest plot

2

Peto Odds Ratio (Peto, Fixed, 95% CI)

Subtotals only

15.1 at baseline

2

140

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.83 [0.38, 1.82]

15.2 at end of course

2

99

Peto Odds Ratio (Peto, Fixed, 95% CI)

2.44 [0.94, 6.32]

15.3 at 2 to 8 weeks

2

76

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.44 [0.17, 1.14]

15.4 Difference between baseline and 2 to 8 weeks

1

29

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.27 [0.06, 1.18]

Figuras y tablas -
Comparison 1. Single versus combination, symptomatic regimen